November 29, 2012 at 17:00 PM EST
Medivation Announces Participation at Upcoming Investor Conferences

SAN FRANCISCO, CA -- (Marketwire) -- 11/29/12 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will present at the following conferences:

  • David Hung, M.D., president and chief executive officer, will present at the Deutsche Bank BioFEST Conference on December 3 at 9:35am Eastern Time in Boston, MA.
  • David Hung, M.D., president and chief executive officer, will present at the JP Morgan Healthcare Conference on January 7 at 4:30pm Pacific Time in San Francisco, CA.

About Medivation
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at www.medivation.com.

Contacts:
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101

Anne Bowdidge
Sr. Director
Investor Relations
(650) 218-6900

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
//-->